RT Journal Article
SR Electronic
T1 A novel cell type negatively associated with secondary autoimmunity in alemtuzumab-treated patients is revealed through single-cell longitudinal analysis of clinical trial samples
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.21.21258814
DO 10.1101/2021.06.21.21258814
A1 Richa Hanamsagar
A1 Mathew Chamberlain
A1 Srinivas Shankara
A1 Robert Marcus
A1 Darren P. Baker
A1 Evis Havari
A1 Katherine Klinger
A1 Frank O. Nestle
A1 Emanuele de Rinaldis
A1 Virginia Savova
YR 2021
UL http://medrxiv.org/content/early/2021/06/28/2021.06.21.21258814.abstract
AB Alemtuzumab, a humanized anti-CD52 monoclonal antibody, is an approved treatment for relapsing forms of multiple sclerosis (RMS). While its efficacy has been demonstrated in clinical studies, its use is associated with unpredictable non-MS autoimmunity manifesting months or years after treatment. Approximately 40% of treated patients present with autoimmune thyroid events, 2% with platelet deficiency (immune thrombocytopenia; ITP)1, and 0.34% with autoimmune nephropathies2. The lack of predictive biomarkers necessitates careful monitoring in clinical practice with a Risk Management Plan or Risk Evaluation and Mitigation Strategy (RMP/REMS) in place for early detection of these autoimmune events. We carried out a longitudinal single-cell analysis of PBMCs in a small subset of alemtuzumab-treated patients from the phase 3 CARE-MS I (CAMMS323) study3 and identified a novel platelet lineage cell negatively associated with thyroid autoimmunity. This discovery raises the possibility that a shared underlying mechanism may contribute to the incidence of thyroid autoimmunity and ITP in alemtuzumab-treated patients.HighlightsA novel platelet-lineage cell type present in peripheral blood is uncovered and characterizedDepletion and/or transcriptomic changes in this cell type are associated with increased incidence of secondary autoimmunity in MS patients on Alemtuzumab.Retrospective single-cell analysis studies can uncover novel insights and lead to future biomarker developmentCompeting Interest StatementAuthors are employees of Sanofi USClinical TrialNCT00530348, NCT00930553Funding StatementWork was funded by SanofiAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This trial is registered with ClinicalTrials.gov (NCT00530348; NCT00930553). All procedures were approved by local institutional ethics review boards of participating sites (see full list below). Patients provided written informed consent. Full list of sites: United States, Alabama North Central Neurology Associates, P.C. Cullman, Alabama, United States United States, Arizona Barrow Neurological Institute, St. Joseph's Hospital & Medical Center Phoenix, Arizona, United States Mayo Clinic Arizona Scottsdale, Arizona, United States Northwest NeuroSpecialists, PLLC Tucson, Arizona, United States United States, Colorado Advanced Neurosciences Research Fort Collins, Colorado, United States United States, Florida Neurological Associates Pompano Beach, Florida, United States Axiom Clinical Research of Florida Tampa, Florida, United States United States, Idaho Idaho Falls Multiple Sclerosis Center, PLLC Idaho Falls, Idaho, United States United States, Illinois Consultants in Neurology, Ltd. Northbrook, Illinois, United States United States, Indiana Fort Wayne Neurological Center Fort Wayne, Indiana, United States United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States MidAmerican Neuroscience Institute Lenexa, Kansas, United States United States, Kentucky Associates in Neurology, PSC Lexington, Kentucky, United States University of Louisville Research Foundation Louisville, Kentucky, United States United States, Louisiana Louisiana State University Health Sciences Center Shreveport, Louisiana, United States United States, Massachusetts UMass Memorial Medical Center Worcester, Massachusetts, United States United States, Michigan University of Michigan Health System Ann Arbor, Michigan, United States Wayne State University Detroit, Michigan, United States United States, Nevada University of Nevada School of Medicine Las Vegas, Nevada, United States United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States United States, New Mexico University of New Mexico, Health Sciences Center, MS Specialty Clinic Albuquerque, New Mexico, United States United States, New York Empire Neurology Latham, New York, United States Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates, P.C. Patchogue, New York, United States University of Rochester Medical Center Rochester, New York, United States United States, North Carolina Carolinas Medical Center (CMC), Neurosciences & Spine Institute (NSSI) Charlotte, North Carolina, United States United States, Ohio The Ohio State University Medical Center, Multiple Sclerosis Center Columbus, Ohio, United States Oak Clinic for Multiple Sclerosis Uniontown, Ohio, United States United States, Oklahoma MS Center of Oklahoma Oklahoma City, Oklahoma, United States United States, Pennsylvania Lehigh Valley Hospital Neurosciences and Pain Research Allentown, Pennsylvania, United States United States, Tennessee Advanced Neurosciences Institute Franklin, Tennessee, United States Biomedical Research Alliance of NY, LLC Franklin, Tennessee, United States Hope Neurology PC Knoxville, Tennessee, United States United States, Texas Baylor College of Medicine, Maxine Mesinger MS Clinic Houston, Texas, United States Central Texas Neurology Round Rock, Texas, United States Integra Clinical Research San Antonio, Texas, United States Neurology Center of San Antonio San Antonio, Texas, United States Argentina DIABAID Buenos Aires, Argentina Australia, Queensland The Wesley Research Institute Auchenflower, Queensland, Australia, 4066 Griffith University School of Medicine Southport, Queensland, Australia Australia, South Australia The Queen Elizabeth Hospital Woodville South, South Australia, Australia Australia, Tasmania Royal Hobart Hospital Hobart, Tasmania, Australia, 7000 Australia, Victoria St Vincent's Hospital Fitzroy, Victoria, Australia, 3065 Austin Health Heidelberg, Victoria, Australia, 3084 Royal Melbourne Hospital, Department of Neurology, Ward 4 East Parkville, Victoria, Australia, 3050 Australia Concord Repatriation General Hospital Concord, Australia Westmead Hospital Westmead, Australia Brazil Hospital da Restauracao, Av Governador Agamenon Magalhaes Recife, Pernambuco, Brazil Hospital Sao Lucas PUC-RS Porto Alegre, RS, Brazil Hospital de Clinicas USP Sao Paulo, SP, Brazil Canada, Alberta University of Calgary and Foothills Medical Cenre Calgary, Alberta, Canada Canada, British Columbia UBC Hospital Vancouver, British Columbia, Canada Canada, Ontario The Ottawa Hospital, General Campus Ottawa, Ontario, Canada Canada, Quebec Clinique Nuero-outaouais Gatineau, Quebec, Canada Clinique Neuro rive-sud, Recherche Sepmus, Inc. Greenfield park, Quebec, Canada Croatia Clinical Hospital Centre Rijeka Rijeka, Croatia General Hospital Varazdin Varazdin, Croatia Clinical Hospital Centre "Sestre Milosrdnice" Zagreb, Croatia Clinical Hospital Centre Zagreb Zagreb, Croatia General Hospital "Sveti Duh" Zagreb, Croatia Czech Republic Department of Neurology, 1st Faculty of Medicine and General Teaching Hospital Praha 2, Czech Republic Krajska zdravotni a.s., Hospital Teplice Teplice, Czech Republic France Hopital Purpan Toulouse, France Germany Judisches Krankenhaus Berlin Berlin, Germany Universitaetsklinik Carl Gustav Carus Dresden Dresden, Germany Klinikum der Goethe Universitaet Frankfurt Frankfurt, Germany Medizinische Hochschule Hannover Hannover, Germany Oberhavelkliniken Hennigsdorf Hennigsdorf, Germany Asklepios Klinikum Brandenburg Teupitz, Germany Mexico Hospital Angeles del Pedregal, Camino de Santa Teresa Mexico City, Mexico Hospital Medica Sur CIF-BIOTEC Mexico City, Mexico Poland Clinical Neurology Centre Sp. z o.o. (Ltd) Cracow, Poland Independent Public Healthcare Facility, Norbert Barlicki University Hospital No. 1 of the Medical University of Lodz Lodz, Poland Independent Public Teaching Hospital No. 4 in Lublin Lublin, Poland Heliodor Swiecicki Teaching Hospital of the Poznan University of Medical Sciences Poznan, Poland Russian Federation Research Medical Complex "Your Health" Ltd Kazan, Russian Federation Moscow City Hospital #11 Moscow, Russian Federation Moscow State Medical Institution City Clinical Hospital #11 Moscow, Russian Federation Scientific Neurology Center RAMS Moscow, Russian Federation Municipal City Hospital #33 Nizhniy Novgorod, Russian Federation Federal State Institution Siberian Rettitorial Medical Center under Federal Medical-Biological Agency of Russia Novosibirsk, Russian Federation City Clinical Hospital #2 Pyatigorsk, Russian Federation Samara Regional Clinical Hospital n.a. Kalinin Samara, Russian Federation Institute of Human Brain RAS St. Petersburg, Russian Federation Nikolaevskaya Hospital St. Petersburg, Russian Federation St. Petersburg Pavlov State Medical University St. Petersburg, Russian Federation State Medical Institution: Republican Clinical Hospital n.a. G.G. Kuvatov Ufa, Russian Federation Serbia Clinical Centre Serbia, Institute for Neurology Belgrade, Serbia Military Medical Academy Belgrade, Serbia Clinical centre Kragujevac Kragujevac, Serbia Clinical Center Nis, Clinic for neurology Nis, Serbia Clinical Centre of Vojvodina, Clinic for neurology Novi Sad, Serbia Sweden Sahlgrenska University Hospital Goteborg, Sweden Ukraine Chernihiv Regional Hospital Chernihiv, Ukraine Institute of Neurology, Psychiatry and Narcology under the Academy of Medical Sciences of Ukraine, Department of Neuroinfection and Multiple Sclerosis Kharkiv, Ukraine Hospoital of the Directorate of the Medical Corps within the Ukrainian Security Service, Neurology Department Kyev, Ukraine Kyev Municipal Clinical Hospital #4 Kyev, Ukraine Danylo Halytsky Lviv National Medical University Lviv, Ukraine United Kingdom Department Of Neurosciences, Addenbrookes Hospital Cambridge, England, United Kingdom Centre for Neuroscience & Trauma, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry London, England, United Kingdom University Hospital of Wales Cardiff, Wales, United Kingdom Royal Hallamshire Hospital Sheffield, United KingdomAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon final publication